Comparative in vitro potency of gemifloxacin against European respiratory tract pathogens isolated in the Alexander Project

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue TOPIC T1, 2000, Pages 11-15

  Marchese, A ^a   Debbia, E A ^a   Schito, G C ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; GEMIFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; COMPARATIVE STUDY; CONTROLLED STUDY; DILUTION; DRUG POTENCY; DRUG SENSITIVITY; EUROPE; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0033910452     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jac.a020888     Document Type: Article

References (27)

1. Mandell, L. A. (1995). Community-acquired pneumonia: etiology, epidemiology and treatment. Chest 108, 35S-42S.
2. Ball, P. (1995). Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest 108, 43S-52S.
3. Goldstein, F., Bryskier, A., Appelbaum, P. C., Bauernfeind, A., Jacobs, M., Schito, G. C. et al. (1998). The etiology of respiratory tract infections and the antibacterial activity of fluoroquinolones and other oral bacterial agents against respiratory pathogens. Clinical Microbiology and Infection 4, Suppl. 2, S8-18.
4. Felmingham, D., Grüneberg, R. N. & the Alexander Project Group. (1996). A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993. The Alexander Project. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 1-57.
5. Grüneberg, R. N. & Felmingham, D. (1996). Results of the Alexander Project: a continuing, multicenter study of the antimicrobial susceptibility of community-acquired, lower respiratory tract bacterial pathogens. Diagnostic Microbiology and Infectious Disease 25, 169-81.
6. Jevons, G., Andrews, J. & Wise, R. (1999). The tentative breakpoint of gemifloxacin, a new fluoroquinolone. Abstract P460. Journal of Antimicrobial Chemotherapy 44, Suppl. A, 141.
7. Jones, R. N. (1996). The emergent needs for basic research, education and surveillance of antimicrobial resistance; problems facing the report from the American Society for Microbiology Task Force on Antimicrobial Resistance. Diagnostic Microbiology and Infectious Disease 25, 153-61.
8. House of Lords Select Committee on Science and Technology. (1998). Seventh Report. Resistance to Antibiotics and other Antimicrobial Agents. The Stationery Office, London.
9. Goldstein, F. W. & Acar, J. F. (1996). Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae - results of a 1992-1993 Western European and United States collaborative surveillance study. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 71-84.
10. Schito, G. C., Mannelli, S., Pesce, A. & the Alexander Project Group (1997). Trends in the activity of macrolide and β-lactam antibiotics and resistance development. Journal of Chemotherapy 9, Suppl. 3, 18-28.
11. Marchese, A., Tonoli, E., Debbia, E. A. & Schito, G. C. (1999). Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy. Journal of Antimicrobial Chemotherapy 44, 461-4.
12. Schito, G. C., Debbia, E. A. & Marchese, A. (2000). The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project. Journal of Antimicrobial Chemotherapy 46, Topic T1, 3-9.
13. National Committee for Clinical Laboratory Standards. (1999). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition: Approved Standard M100-S9. NCCLS, Wayne, PA.
14. King, A., May, J., French, G. & Phillips, I. (1999). The comparative in vitro activity of gemifloxacin, a new fluoroquinolone, against selected clinical isolates. Abstract P488. Journal of Antimicrobial Chemotherapy 44, Suppl. A, 147.
15. Dubois, J. & St-Pierre, C. (1999). Comparative in vitro activity of gemifloxacin and other quinolones against maxillary sinus pathogens. Abstract P429. Journal of Antimicrobial Chemotherapy 44, Suppl. A, 135.
16. Boswell, F., Andrews, J. & Wise, R. (1999). The comparative in-vitro activity of gemifloxacin, a novel fluoroquinolone. Abstract P413. Journal of Antimicrobial Chemotherapy 44, Suppl. A, 132.
17. Felmingham, D., Robbins, M., Dencer, C., Salman H., Mathias, I. & Ridgway, G. (1999). In-vitro activity of gemifloxacin against S. pneumoniae, H. influenzae, M. catarrhalis, L. pneumophila and Chlamydia spp. Abstract P408. Journal of Antimicrobial Chemotherapy 44, Suppl. A, 131.
18. Hardy, D., Amsterdam, D., Mandell, L. & Rotstein, C. (1999). Comparative in vitro activity of gemifloxacin, moxifloxacin, trovafloxacin, sparfloxacin, grepafloxacin, ofloxacin, ciprofloxacin and other antimicrobial agents against bloodstream isolates of Grampositive cocci. Journal of Antimicrobial Chemotherapy 44, Suppl. A, 146.
19. Marchese, A.,Tonoli, E., Dolcino, M., Debbia, E. A. & Schito, G. C. (1999). Comparative in vitro activity of gemifloxacin (SB-265805), a new fluoroquinolone, against respiratory tract pathogens. In Program and Abstracts of the Thirty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA, 1999, Abstract 2300, p. 278. American Society for Microbiology, Washington, DC.
20. Morrisey, I. & George, J. (1999). The bactericidal activity of gemifloxacin and other fluoroquinolones against S. pneumoniae. Abstract P487. Journal of Antimicrobial Chemotherapy 44, Suppl. A, 147.
21. Fukuda, H. & Hiramatsu, K. (1999). Primary targets of fluoroquinolones in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 43, 410-2.
22. Pan, X. S. & Fisher, L. M. (1999). Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression, purification, and differential inhibition by fluoroquinolones. Antimicrobial Agents and Chemotherapy 43, 1129-36.
23. Brenwald, N., Gill, M., Boswell, F. & Wise, R. (1999). Activity of gemifloxacin against S. pneumoniae strains resistant to fluoroquinolones by an efflux mechanism. Abstract P477. Journal of Antimicrobial Chemotherapy 44, Suppl. A, 145.
24. Niconovich, N., Rittenhouse, S. & Coleman, K. (1999). Comparative antibacterial activity of gemifloxacin against H. influenzae and H. parainfluenzae. Abstract P462. Journal of Antimicrobial Chemotherapy 44, Suppl. A, 142.
25. Felmingham, D. (1995). Antibiotic resistance: do we need new therapeutic approaches? Chest 108, 70S-78S.
26. Catlin, B. W. (1990). Branhamella catarrhalis, an organism gaining respect as a pathogen. Clinical Microbiology Reviews 3, 293-320.
27. Jorgensen, J. H., Doern, G. V., Maher, L. A., Howell, A. W. & Redding, J. S. (1990). Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrobial Agents and Chemotherapy 34, 2075-80.